Biotech · Public company · Philadelphia, PA, US

Century Therapeutics, Inc.

Ticker IPSC · SEC CIK 0001850119

Track this companyFree. Adds Century Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.

Clinical trials32 recruiting or active

Pipeline programs7From trials and the company's site

Disclosed deals0None found yet

Cash runwayNot availableNo recent cash burn filed

Pipeline7

CNTY-101Phase 1 · R/R CD19-Positive B-Cell MalignanciesClinicalTrials.gov · fetched Nov 12, 2026
CNTY-101Phase 1 · Systemic Lupus ErythematosusClinicalTrials.gov · fetched Nov 12, 2026
IL-2Phase 1 · R/R CD19-Positive B-Cell MalignanciesClinicalTrials.gov · fetched Nov 12, 2026
IL-2Phase 1 · Systemic Lupus ErythematosusClinicalTrials.gov · fetched Nov 12, 2026
Lymphodepleting ChemotherapyPhase 1 · R/R CD19-Positive B-Cell MalignanciesClinicalTrials.gov · fetched Nov 12, 2026
Lymphodepleting ChemotherapyPhase 1 · Systemic Lupus ErythematosusClinicalTrials.gov · fetched Nov 12, 2026
No InterventionHematological MalignancyClinicalTrials.gov · fetched Nov 12, 2026

A Study of CNTY-101 in Participants With Refractory B Cell-mediated Autoimmune DiseasesPHASE1 · ACTIVE_NOT_RECRUITING · started Feb 6, 2025ClinicalTrials.gov NCT06255028 · fetched Nov 12, 2026
A Study for Participants Previously Treated With Century Therapeutics Cellular Therapy ProductRECRUITING · started Apr 29, 2024ClinicalTrials.gov NCT05768269 · fetched Nov 12, 2026
A Study of CNTY-101 in Participants With CD19-Positive B-Cell MalignanciesPHASE1 · TERMINATED · started Jan 24, 2023ClinicalTrials.gov NCT05336409 · fetched Nov 12, 2026